Having established the DFX model of hypoxia and an effective HIF-2α silencing protocol, we next examined the effect of HIF-2α expression on responsiveness to the gold standard chemotherapy for glioblastoma, the alkylating agent TMZ. Here, EPAS1 is linked to glioblastoma.